Treatment of symptomatic prostatic hypertrophy with the KTP-80 laser

Fateri, F.; Caviezel, A.; Saaidia, A.; Iselin, C.

Revue Medicale Suisse 1(44): 2867-2869

2005


ISSN/ISBN: 1660-9379
PMID: 16382721
Document Number: 593958
Macroscopic per and post-operative hematuria contributes significantly to hospitalisation time and to the morbidity of conventional surgery of symptomatic prostatic hypertrophy. It requires in fact transient anti-coagulation interruption, so as eventually a window with platelet anti-agregants. The newly available 80-Watts Potassium-Titanyl-Phosphate laser markedly reduces post-operative hematuria, and allows operating the increasing population of patients under platelet anti-agregants, or event those who need therapeutic anticoagulation. This series reports on our initial experience with a technique which decreases remarkably post-operative catheterization and hospitalisation time, and whose obstruction relief is efficient, but needs to stand the test of time.

Document emailed within 1 workday
Secure & encrypted payments